Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
TARS: Tarsus Pharmaceuticals, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
TARS
The Story
TARS
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+948.6% / yr
Operating margin
-9.5%
ROIC
-11.5%
Financially safe
Stretched
Debt / equity
0.25×
Interest coverage
-5.9×
Current ratio
3.74×
Tarsus Pharmaceuticals, Inc.
TARS
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Tarsus Pharmaceuticals, Inc.
TARS
NASDAQ
·
USD
·
Closed
$59.04
−0.84%
$59.04
−$0.50 (0.84%)
52W Range
44th
pctl
Volume
0.57×
avg
Mkt Cap
2.54B
USD
P/E
-51.8
TTM
Div Yield
–
ann
52W Range
44th
pctl
Volume
0.57×
avg
Market Cap
2.54B
USD
P/E Ratio
-51.8
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings